The emerging role of soluble HLA-G in the control of chemotaxis

Fabio Morandi, Nathalie Rouas-Freiss, Vito Pistoia

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

HLA-G is an immunosuppressive molecule, that impairs the function of different immune cell populations, both in physiological and pathological conditions. Here, we have analyzed data obtained by our group and others regarding sHLA-G concentration in plasma from patients with different diseases. Next, we have summarized novel data regarding the impairment of chemotaxis of different immune effector cells mediated by sHLA-G. Finally, we have discussed the impact of this function on the immune response during cancer, viral infection, autoimmunity, and on B cell differentiation in secondary lymphoid organs. In conclusion, we have delineated a role of sHLA-G in the control of chemotaxis of immune effector cells, that may be relevant to modulate immune responses in different settings.

Original languageEnglish
Pages (from-to)327-335
Number of pages9
JournalCytokine and Growth Factor Reviews
Volume25
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

HLA-G Antigens
Chemotaxis
Cells
Immunosuppressive Agents
Virus Diseases
Autoimmunity
Plasmas
Molecules
Cell Differentiation
B-Lymphocytes
Population
Neoplasms

Keywords

  • Chemokine receptors
  • Chemotaxis
  • HLA-G

ASJC Scopus subject areas

  • Immunology
  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

The emerging role of soluble HLA-G in the control of chemotaxis. / Morandi, Fabio; Rouas-Freiss, Nathalie; Pistoia, Vito.

In: Cytokine and Growth Factor Reviews, Vol. 25, No. 3, 2014, p. 327-335.

Research output: Contribution to journalArticle

@article{d24aba945c5e4193878175bcb4ba761d,
title = "The emerging role of soluble HLA-G in the control of chemotaxis",
abstract = "HLA-G is an immunosuppressive molecule, that impairs the function of different immune cell populations, both in physiological and pathological conditions. Here, we have analyzed data obtained by our group and others regarding sHLA-G concentration in plasma from patients with different diseases. Next, we have summarized novel data regarding the impairment of chemotaxis of different immune effector cells mediated by sHLA-G. Finally, we have discussed the impact of this function on the immune response during cancer, viral infection, autoimmunity, and on B cell differentiation in secondary lymphoid organs. In conclusion, we have delineated a role of sHLA-G in the control of chemotaxis of immune effector cells, that may be relevant to modulate immune responses in different settings.",
keywords = "Chemokine receptors, Chemotaxis, HLA-G",
author = "Fabio Morandi and Nathalie Rouas-Freiss and Vito Pistoia",
year = "2014",
doi = "10.1016/j.cytogfr.2014.04.004",
language = "English",
volume = "25",
pages = "327--335",
journal = "Cytokine and Growth Factor Reviews",
issn = "1359-6101",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - The emerging role of soluble HLA-G in the control of chemotaxis

AU - Morandi, Fabio

AU - Rouas-Freiss, Nathalie

AU - Pistoia, Vito

PY - 2014

Y1 - 2014

N2 - HLA-G is an immunosuppressive molecule, that impairs the function of different immune cell populations, both in physiological and pathological conditions. Here, we have analyzed data obtained by our group and others regarding sHLA-G concentration in plasma from patients with different diseases. Next, we have summarized novel data regarding the impairment of chemotaxis of different immune effector cells mediated by sHLA-G. Finally, we have discussed the impact of this function on the immune response during cancer, viral infection, autoimmunity, and on B cell differentiation in secondary lymphoid organs. In conclusion, we have delineated a role of sHLA-G in the control of chemotaxis of immune effector cells, that may be relevant to modulate immune responses in different settings.

AB - HLA-G is an immunosuppressive molecule, that impairs the function of different immune cell populations, both in physiological and pathological conditions. Here, we have analyzed data obtained by our group and others regarding sHLA-G concentration in plasma from patients with different diseases. Next, we have summarized novel data regarding the impairment of chemotaxis of different immune effector cells mediated by sHLA-G. Finally, we have discussed the impact of this function on the immune response during cancer, viral infection, autoimmunity, and on B cell differentiation in secondary lymphoid organs. In conclusion, we have delineated a role of sHLA-G in the control of chemotaxis of immune effector cells, that may be relevant to modulate immune responses in different settings.

KW - Chemokine receptors

KW - Chemotaxis

KW - HLA-G

UR - http://www.scopus.com/inward/record.url?scp=84902077948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902077948&partnerID=8YFLogxK

U2 - 10.1016/j.cytogfr.2014.04.004

DO - 10.1016/j.cytogfr.2014.04.004

M3 - Article

C2 - 24882150

AN - SCOPUS:84902077948

VL - 25

SP - 327

EP - 335

JO - Cytokine and Growth Factor Reviews

JF - Cytokine and Growth Factor Reviews

SN - 1359-6101

IS - 3

ER -